Iria
Bastón Rey
Publications (25) Iria Bastón Rey publications
2024
-
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 18, Núm. 1, pp. 65-74
-
Effectiveness and safety of azathioprine for inflammatory pouch disorders: results from the RESERVO study of GETECCU
Therapeutic Advances in Gastroenterology, Vol. 17
-
Efficacy and safety of biological treatment for inflammatory bowel disease in elderly patients: Results from a GETECCU cohort
Gastroenterologia y Hepatologia
2023
-
Enfermedad inflamatoria intestinal
Microbiota, probióticos y prebióticos: evidencia científica (Ergon), pp. 389-392
-
Is Occupation a Risk Factor for Developing Inflammatory Bowel Disease? A Case–Control Study
Crohn's and Colitis 360, Vol. 5, Núm. 4
-
Managing ulcerative colitis after surgery
Frontiers in Medicine
2022
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Radon exposure and inflammatory bowel disease in a radon prone area
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 7, pp. 405-409
-
Usefulness of peripheral blood monocyte count to predict relapse in patients with inflammatory bowel disease: a prospective longitudinal cohort study
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 1, pp. 10-15
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2021
-
Impact of biological agents on postsurgical complications in inflammatory bowel disease: A multicentre study of geteccu
Journal of Clinical Medicine, Vol. 10, Núm. 19
-
Role of quality of life as endpoint for inflammatory bowel disease treatment
International Journal of Environmental Research and Public Health, Vol. 18, Núm. 13
2020
-
Diagnostic protocol for oesophageal chest pain
Medicine (Spain), Vol. 13, Núm. 7, pp. 401-404
-
Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard-dose subcutaneous maintenance therapy
Alimentary Pharmacology and Therapeutics, Vol. 52, Núm. 1, pp. 135-142
-
Pancreatitis aguda
Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 9, pp. 467-476
-
Pouchitis: Treatment dilemmas at different stages of the disease
United European Gastroenterology Journal, Vol. 8, Núm. 3, pp. 256-262
-
Protocolo diagnóstico del dolor torácico esofágico
Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 7, pp. 401-404
-
Should We Investigate Respiratory Diseases in Inflammatory Bowel Disease Patients?
Archivos de Bronconeumologia
2019
-
Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
Therapeutic Advances in Gastroenterology, Vol. 12
-
Bismuth-containing quadruple therapy versus concomitant quadruple therapy as first-line treatment for Helicobacter Pylori infection in an area of high resistance to clarithromycin: A prospective, cross-sectional, comparative, open trial
Helicobacter, Vol. 24, Núm. 1